Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs 3M Company (MMM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs 3M Company — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69.47 (market cap $30.93B), while 3M Company trades at $165.97 (market cap $84.82B). The key difference: 3M Company is far larger — about 2.7× GE HealthCare Technologies Inc. Common Stock's market cap, and 3M Company pays the higher dividend (1.9%). Which is the better fit depends on your goals.
| GEHC | MMM | |
|---|---|---|
Market Cap | $30.93B | $84.82B |
Volume | 5,033,451 | 2,697,631 |
Sector | Health | Industrials |
52-Week High | $88.16 | $183.79 |
52-Week Low | $59.48 | $141.10 |
Enterprise Value | $39.39B | $94.04B |
Dividend Yield | 0.23% | 1.9% |
Typical Hold Time | — | 169 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
3M (MMM) trades at $162.77, up 1.17% with a bearish technical signal despite recent earnings beats. The stock shows strong profitability with 11.9% net margin and 82.77% ROE, though revenue declined from $34.2B in 2022 to $24.95B in 2025. Analyst consensus is mixed with 48% buy ratings and a $191 price target, while technical indicators show support at $156 and resistance at $163. Recent news highlights operational improvements and litigation resolution progress.
MMM presents a turnaround opportunity with margin expansion and shareholder returns, but faces headwinds from weak consumer demand and high debt levels. The stock's valuation appears stretched at 29x P/E, requiring sustained execution to justify upside. Key risks include consumer segment challenges and economic sensitivity, while catalysts include industrial growth and cost management initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About 3M Company
3M Company conducts operations in electronics, telecommunications, industrial, consumer and office, health care, safety, and other markets. The Company businesses share technologies, manufacturing operations, marketing channels, and other resources. 3M serves customers worldwide.
Read more on MMM →
